Understanding the LEAD ACO Model and Its Impact on Medicare's Future

For over a decade, Medicare has sought to transition healthcare providers from traditional volume-based reimbursements to value-driven care delivery. Central to this transition are Accountable Care Organizations (ACOs), outlined by the Centers for Medicare & Medicaid Services (CMS) as groups that assume responsibility for the quality and total cost of patient care.

The latest development in ACO structures is the Long-Term Enhanced ACO Design (LEAD). ACOs function within Medicare, Medicaid, and the private sector to ensure providers remain accountable for both quality and financial elements of care. CMS aims to enroll all Medicare beneficiaries into accountable care models by 2030.

Currently, ACOs and Medicare Advantage plans cover 50.2 million people, with 35.9 million in Medicare Advantage and 14.3 million in ACOs. Around 20 million beneficiaries still operate under the traditional fee-for-service model, not yet aligned with accountable care models.

The LEAD ACO model addresses previous limitations by employing a "whole TIN" approach, managing participation at the tax identification number level. This structure includes physician groups, hospital networks, and healthcare centers, which partake in beneficiary alignment, quality reporting, and capitation payments.

Additionally, LEAD ACOs may involve "preferred providers" not directly accountable for alignment criteria but who support the ACO in managing care effectively. These providers, often specialists or post-acute care professionals, operate at the TIN-NPI level, potentially engaging in capitation payment agreements.

Financial mechanisms within LEAD ACOs include benchmarks based on historical expenditure, adjusted for regional efficiencies and risk factors. ACOs have the choice between a professional risk model with a 50% risk share and a global model with a 100% risk share. The capitation payment choice, whether for primary care or total cost of care, encourages upfront investments and moves away from volume-based compensations.

The LEAD model also offers advanced payment options and sophisticated CMS-administered risk arrangements. The inclusion of quality withholds emphasizes performance measures, such as diabetes and high blood pressure metrics. CMS has also introduced support structures like the Tech Enabler Initiative to promote best practices. Hospitals and physician practices considering LEAD ACO participation should evaluate the financial opportunities and risks, aligning strategically with value-based care initiatives. CLA can assist in navigating these aspects for readiness and success in evolving care models.